WallStreetZenWallStreetZen

NASDAQ: ICAD
Icad Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for ICAD

Based on 4 analysts offering 12 month price targets for Icad Inc.
Min Forecast
$7.00+211.11%
Avg Forecast
$9.75+333.33%
Max Forecast
$16.00+611.11%

Should I buy or sell ICAD stock?

Based on 5 analysts offering ratings for Icad Inc.
Buy
Strong Buy
2 analysts 40%
Buy
2 analysts 40%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ICAD stock forecasts and price targets.

ICAD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
JMP Securities
Bottom 12%
12
BuyMaintains$7.00+211.11%2022-09-01
Lake Street
Bottom 3%
3
Strong BuyMaintains$8.00+255.56%2022-08-11
BTIG
Top 8%
93
Strong BuyMaintains$8.00+255.56%2022-06-24
Guggenheim
Bottom 18%
18
HoldDowngradesN/AN/A2022-01-18
Oppenheimer
Bottom 6%
6
BuyMaintains$16.00+611.11%2022-01-05

1 of 1

Forecast return on equity

Is ICAD forecast to generate an efficient return?
Company
-37.7%
Industry
4.69%
Market
98.76%
ICAD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ICAD forecast to generate an efficient return on assets?
Company
-26.47%
Industry
2.59%
ICAD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ICAD earnings per share forecast

What is ICAD's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.54
Avg 2 year Forecast
-$0.61

ICAD revenue forecast

What is ICAD's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$33.1M+2.67%
Avg 2 year Forecast
$45.2M+40.05%
ICAD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICAD revenue growth forecast

How is ICAD forecast to perform vs Health Information Services companies and vs the US market?
Company
2.67%
Industry
8.03%
Market
12.8%
ICAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICAD vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
ICAD$2.25$9.75+333.33%Buy
AUGX$1.51N/AN/A
STRM$1.15$3.00+160.87%Strong Buy
MTBC$4.42$11.00+148.87%Strong Buy
NH$0.38$3.25+755.26%Strong Buy
View Top Health Information Service Stocks

Icad Stock Forecast FAQ

Is Icad Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ICAD) stock is to Buy ICAD stock.

Out of 5 analysts, 2 (40%) are recommending ICAD as a Strong Buy, 2 (40%) are recommending ICAD as a Buy, 1 (20%) are recommending ICAD as a Hold, 0 (0%) are recommending ICAD as a Sell, and 0 (0%) are recommending ICAD as a Strong Sell.

If you're new to stock investing, here's how to buy Icad stock.

What is ICAD's earnings growth forecast for 2022-2023?

(NASDAQ: ICAD) Icad's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 5.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 46.52%.

Icad's earnings in 2022 is -$12,985,000.On average, 1 Wall Street analyst forecast ICAD's earnings for 2022 to be -$13,680,325, with the lowest ICAD earnings forecast at -$13,680,325, and the highest ICAD earnings forecast at -$13,680,325.

In 2023, ICAD is forecast to generate -$15,453,700 in earnings, with the lowest earnings forecast at -$15,453,700 and the highest earnings forecast at -$15,453,700.

What is ICAD's revenue growth forecast for 2022-2023?

(NASDAQ: ICAD) Icad's forecast annual revenue growth rate of 2.67% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.03%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.8%.

Icad's revenue in 2022 is $32,267,000.On average, 1 Wall Street analysts forecast ICAD's revenue for 2022 to be $839,313,267, with the lowest ICAD revenue forecast at $839,313,267, and the highest ICAD revenue forecast at $839,313,267.

In 2023, ICAD is forecast to generate $1,144,840,523 in revenue, with the lowest revenue forecast at $1,144,840,523 and the highest revenue forecast at $1,144,840,523.

What is ICAD's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: ICAD) forecast ROA is -26.47%, which is lower than the forecast US Health Information Services industry average of 2.59%.

What is ICAD's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ICAD price target, the average ICAD price target is $9.75, with the highest ICAD stock price forecast at $16.00 and the lowest ICAD stock price forecast at $7.00.

On average, Wall Street analysts predict that Icad's share price could reach $9.75 by Sep 1, 2023. The average Icad stock price prediction forecasts a potential upside of 333.33% from the current ICAD share price of $2.25.

What is ICAD's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: ICAD) Icad's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that ICAD's EPS will be -$0.54 for 2022, with the lowest EPS forecast at -$0.54, and the highest EPS forecast at -$0.54. In 2023, ICAD's EPS is forecast to hit -$0.61 (min: -$0.61, max: -$0.61).

What is ICAD's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: ICAD) forecast ROE is -37.7%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.